Cara Therapeutic (CARA) Financials

$5.32

$-11.33 (-68.05%)

As on 15-Apr-2025 16:00EDT

Market cap

$8 Mln

Revenue (TTM)

$7 Mln

P/E Ratio

--

P/B Ratio

1.5

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Operating Revenue	7.14	20.97	41.87	23.03	135.08	19.89
Cost of Revenue	0.62	6.17	7.27	1.55	107.07	113.82
Gross Profit	7.14	14.79	34.60	23.03	28.01	19.89
Operating Expenses	65.52	136.29	122.14	112.11	129.70	131.57
Operating Profit (EBIT)	-58.38	-121.50	-87.54	-89.08	5.39	-111.68
Other Income	--	--	2.06	0.64	2.33	4.49
Profit before Tax	-71.27	-118.51	-85.47	-88.44	7.72	-107.19
Provision for Tax	-0.40	0.09	-2.06	-0.25	-0.69	-0.82
Profit after Tax (Net Income)	-70.87	-118.51	-83.41	-88.19	8.41	-106.37
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	-85.47	-88.44	8.41	-106.37

Liabilities ($ Mln)	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Shareholder's Funds	-4.59	57.09	158.78	227.52	249.00	186.71
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	44.45	43.17	11.52	1.92	3.67	3.35
Current Liabilities	3.97	25.59	23.46	17.62	18.48	42.89
Total Liabilities	43.83	125.84	182.24	247.06	271.16	232.96

Assets ($ Mln)	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Non-Current Assets	--	9.69	13.33	73.77	76.09	67.30
Current Assets	43.83	116.16	168.91	173.29	195.07	165.66
Total Assets	43.83	125.84	182.24	247.06	271.16	232.96
Total Debt*	--	43.17	1.92	3.67	5.28	4.32
Net Current Assets	39.86	90.57	145.45	155.67	176.58	122.76

Cashflow ($ Mln)	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Cash From Operating Activities	-60.92	-92.08	-78.73	-60.09	-5.49	-109.23
Cash Flow from Investing Activities	--	--	128.71	-4.75	-20.28	-30.52
Cash from Financing Activities	-3.60	38.15	0.31	46.61	39.14	142.60
Net Cash Inflow / Outflow	--	--	50.29	-18.23	13.38	2.86

Financials Ratios	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Adjusted EPS ($)	--	--	--	--	--	--
Cash EPS ($)	--	--	--	--	--	--
Adjusted Book Value ($)	--	--	--	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	--	--	--	--	--
Free Cash Flow per Share ($)	--	--	--	--	--	--

Profitability Ratios	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
ROCE (%)	-148.17	-90.83	-42.57	-36.33	3.78	-65.53
ROE (%)	-270.01	-109.80	-43.19	-37.02	3.86	-66.41
ROA (%)	-83.53	-76.94	-38.86	-34.04	3.34	-50.20
EBIT Margin (%)	-879.81	-562.33	-209.08	-386.85	3.39	-561.60
Net Margin (%)	-992.95	-565.21	-189.89	-372.59	6.12	-436.38
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Revenue Growth (%)	-0.66	-0.50	0.82	-0.83	5.79	0.48
EBIT Growth (%)	46.75	-34.70	1.74	-2,045.47	104.10	-44.32
Net Profit Growth (%)	40.20	-42.08	5.42	-1,148.67	107.91	-43.72
EPS Growth (%)	--	--	--	--	--	--
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Price / Earnings	--	--	--	--	--	--
Price / Book Value	--	--	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	0.61	0.49	1.64	1.84	-31.40	1.35
Close Price ($)	18.36	26.75	386.64	438.48	544.68	579.96
High Price ($)	41.40	449.64	502.74	1,067.30	688.83	991.80
Low Price ($)	8.13	20.52	266.40	403.92	319.68	461.88
Market Cap ($ Cr)	--	--	--	--	--	--

Solvency Ratios	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Debt to Equity	--	0.76	0.01	0.02	0.02	0.02
Short term debt to equity ratio	--	--	0.02	0.02	0.01	0.01
Current Ratio	11.03	4.54	7.20	9.84	10.55	3.86
Quick Ratio	10.81	4.43	7.10	9.69	10.64	3.88
Interest Coverage	-7.41	-195.21	-352.96	-359.21	1.96	-23.82

Operating Efficiency Ratios	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Debtors to sales (%)	62.98	19.16	10.64	5.00	1.53	8.99
Asset Turnover	0.08	0.14	0.20	0.09	0.54	0.09
Receivable days	217.81	73.77	24.45	25.50	5.21	31.01
Inventory Days	1,096.04	153.93	124.84	126.57	-3.96	-2.62
Payable days	3,834.24	626.70	382.77	1,236.07	23.87	21.61
Cash Conversion Cycle	-2,520.39	-399.00	-233.48	-1,084.00	-22.62	6.78